scholarly journals A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non–muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

2022 ◽  
Author(s):  
Cyrill A. Rentsch ◽  
George N. Thalmann ◽  
Ilaria Lucca ◽  
Maciej Kwiatkowski ◽  
Grégory J. Wirth ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Bladder Cancer ◽  
Phase 1 ◽  
Cancer Recurrence ◽  
Invasive Bladder Cancer ◽  
Bacillus Calmette Guerin ◽  
Muscle Invasive Bladder Cancer ◽  
Bcg Therapy ◽  
Muscle Invasive ◽  
Bladder Cancer Recurrence

scholarly journals Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions

2020 ◽  
Vol 6 (1) ◽  
pp. 9-23
Author(s):  
Kyle B. Zuniga ◽  
Rebecca E. Graff ◽  
David B. Feiger ◽  
Maxwell V. Meng ◽  
Sima P. Porten ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cancer Recurrence ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Future Directions ◽  
Muscle Invasive ◽  
Bladder Cancer Recurrence
Sign in / Sign up

Export Citation Format

Share Document